Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arizona for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arizona only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arizona (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Joonhee Lim (NPI 1982834321)

Field	Value
Entity Type	Individual
Organization	Joonhee Lim
Address	3645 S Rome St Ste 201
City	Gilbert
State	AZ
ZIP	85297
Taxonomy	Rheumatology Physician
NPI Enumerated	July 20, 2009

Payer Source	Total Paid
Medicare	$2.3M
Medicaid	$0

Key Findings

This provider is effectively single‑payer Medicare: lifetime Medicare revenue is $2.3M and there is no Medicaid billing on file. The absence of any Medicaid activity indicates payer mix is heavily concentrated on Medicare beneficiaries rather than dual or Medicaid-dominant panels.

Revenue is highly concentrated in a small number of infused biologic drugs: the top 3 Medicare codes account for 48.2% of total Medicare revenue, driven by J0129 ($598.4K, 25.6% of Medicare revenue), J3262 ($268.8K, 11.5%), and J0897 ($260.3K, 11.1%). This concentration implies material financial dependence on in-office administration of high-cost injectable biologics.

The procedure and drug mix (multiple J‑codes such as J0129, J3262, J0897, J3111, J1602 and infusion CPTs 96413/96415) indicates an on-site infusion/administration model consistent with a rheumatology practice that directly provides parenteral biologic therapies. Presence of both high-volume biologic J‑codes and chemotherapy/infusion administration CPTs suggests the practice operates an infusion suite or similarly equipped outpatient treatment area.

Competitive standing across specific biologics is mixed: J0897 ranks #579 of 10057 providers nationally (94th percentile; notably above typical national volume for this code), signalling above-typical national activity for denosumab administration. By contrast, J0129 ranks #174 of 1221 (86th percentile; typical, unremarkable volume) and J3262 ranks #211 of 618 (66th percentile; typical, unremarkable volume), indicating the provider is a relatively stronger participant for certain biologics while maintaining typical volumes for others.

Evaluation-and-management billing shows unusually high intensity relative to national peers: 99214 generated $132.4K (5.7% of Medicare revenue) and ranks in the 99th percentile as an extreme outlier, and 99205 generated $27.1K (1.2% of Medicare revenue) and also ranks in the 99th percentile as an extreme outlier. These extreme outlier E/M rankings suggest either a patient panel with high visit complexity or documented coding intensity for prolonged/high-MDM office encounters.

Infusion-support CPTs and related chemotherapy codes are also prominent and above typical peer volumes: 96413 produced $72.6K (3.1% of Medicare revenue) and ranks in the 97th percentile (notably above typical national volume), and 96415 produced $6.2K (0.3% of Medicare revenue) and ranks in the 94th percentile (notably above typical national volume). This reinforces the conclusion that revenue is materially supported by infusion administration services beyond just biologic drug supply.

Provider tenure is long-standing: NPI was enumerated 2009-07-20 (~17 years ago), indicating an established presence in the market that aligns with the development of an infusion-focused practice. Longevity combined with the observed code mix is consistent with an ongoing outpatient specialty practice rather than a short-term or newly established operation.

The practice also orders a variety of in-office laboratory and regionally relevant tests (for example, 86635 had 292 claims and $3.2K revenue and ranks #26 of 87 providers nationally, 71th percentile; 80053 and 86140 appear at relatively high percentiles), suggesting integrated diagnostic services to support rheumatology care and management of regionally endemic conditions. These ancillary services complement the infusion and E/M activity and indicate a comprehensive outpatient service line for the Medicare population.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

46 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	17,600	$30	$598.4K
J3262	Injection, tocilizumab, 1 mg	53,760	$10	$268.8K
J0897	Injection, denosumab, 1 mg	14,460	$20	$260.3K
J3111	Injection, romosozumab-aqqg, 1 mg	28,770	$10	$230.2K
J1602	Injection, golimumab, 1 mg, for intravenous use	22,490	$10	$224.9K
J9312	Injection, rituximab, 10 mg	2,900	$60	$171.1K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	5,500	$30	$137.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,490	$90	$132.4K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	31,000	$1	$124K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	730	$100	$72.6K

Showing 1–10 of 46

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 46 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arizona Distribution

Joonhee Lim — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arizona

Full comparison — all codes billed, vs. state median

46 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	8	30	14,700	$30	$494.5K
J3262	14	20	74,500	$1	$367.2K
J1602	15	30	24,040	$10	$316.2K
J0717	14	20	36,100	$1	$246.6K
J9312	10	20	3,250	$60	$212.6K
J3111	10	40	19,530	$10	$178.8K
J0897	31	260	2,940	$20	$115.6K
J1745	8	40	2,980	$30	$103.9K
86480	17	20	110	$60	$27.2K
86635	12	20	290	$10	$25.8K

Showing 1–10 of 46

Related Providers

Other providers that share a Tax Identification Number (TIN) with Joonhee Lim, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Arizona Arthritis & Rheumatology Associates P C	AZ	Rheumatology Physician	$0	$11.2M
Nehad Soloman	AZ	Rheumatology Physician	$5.1M	$0
Alexander Hu	AZ	Internal Medicine Physician	$3.8M	$0
Areena Swarup	AZ	Rheumatology Physician	$3.6M	$0
Saima Chohan	AZ	Rheumatology Physician	$3.5M	$0
Nikila Kumar	AZ	Rheumatology Physician	$3M	$0
John Tesser	AZ	Rheumatology Physician	$3M	$0
Daniel Kreutz	AZ	Rheumatology Physician	$2.8M	$0
Mona Amin	AZ	Rheumatology Physician	$2.7M	$0
Andrew Sharobeem	AZ	Rheumatology Physician	$2.3M	$0

Nearby Providers

Other providers in the same ZIP code as Joonhee Lim, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Warner Park Surgery Center LLC	AZ	Ambulatory Surgical Clinic/Center	$964.6K	$694.3K
Zaki Lababidi	AZ	Cardiovascular Disease Physician	$1.3M	$0
Naveen Kumar	AZ	Otolaryngology/Facial Plastic Surgery Physician	$1.1M	$0
Surgcenter Chandler, LLC	AZ	Ambulatory Surgical Clinic/Center	$1.1M	$0
Ortho Arizona Surgery Center Gilbert, LLC	AZ	Ambulatory Surgical Clinic/Center	$834.1K	$0
Ocotillo Surgery Center LLC	AZ	Ambulatory Surgical Clinic/Center	$606.2K	$222.1K
Khaled Albasha	AZ	Cardiovascular Disease Physician	$608.2K	$0
Daniel Condie	AZ	Dermatology Physician	$552.8K	$0
Devendra Wadwekar	AZ	Endocrinology, Diabetes & Metabolism Physician	$528.7K	$0
Ahdev Kuppusamy	AZ	Interventional Pain Medicine Physician	$374.3K	$0

Joonhee Lim — Billing Profile & Reimbursement Data

Sign up for Joonhee Lim — Billing Profile & Reimbursement Data policy alerts

Joonhee Lim — Billing Profile & Reimbursement Data

Sign up for Joonhee Lim — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References